CBU
RLAY icon

CIBC Bancorp USA’s Relay Therapeutics RLAY Stock Holding History

CIBC Bancorp USA’s Portfolio RLAY Stock Details RLAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$73.7K Buy
+14,116
New +$53.8K ﹤0.01% 1385

Other funds holding RLAY

SIAU
SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return

CIBC Bancorp USA's RLAY Position: Q3 2025 in Review

CIBC Bancorp USA opened a new position in Relay Therapeutics (RLAY) in Q3 2025: 14,116 shares worth $73.7K. The stake represents ﹤0.01% of the portfolio and ranks #1385 among its holdings.

199 funds tracked by Wall St. Rank hold RLAY as of Q3 2025.

  • CIBC Bancorp USA held 14,116 shares of Relay Therapeutics worth $73.7K as of Q3 2025.
  • Relay Therapeutics was a new CIBC Bancorp USA position in Q3 2025.
  • Relay Therapeutics made up ﹤0.01% of CIBC Bancorp USA's portfolio in Q3 2025, its #1385 holding.
  • 199 funds tracked by Wall St. Rank held Relay Therapeutics as of Q3 2025.

Based on CIBC Bancorp USA's 13F filing for Q3 2025, filed 12 Nov 2025.